Medtronic plc (MDT) : $48.32 million worth of transactions were on upticks in Medtronic plc (MDT), compared to $36.94 million on downticks. The ratio between the two was 1.31, whereas, the net money flow stood at a healthy $11.37 million on Mondays session. The consistent buying on upticks in the stock accounted for $14.19million worth of trades. The total money flow into the stock stood at $14.19 million. The bulls and the bears were in an equilibrium as the stock closed with a loss of -0.19%. The stock was trading at $88.19, with a drop of $0.17 over the previous days close. The stock recorded -0.19% for the week.
Medtronic plc is up 14.17% in the last 3-month period. Year-to-Date the stock performance stands at 15.81%. Medtronic plc has dropped 0.36% in the last five trading days, however, the shares have posted positive gains of 4.77% in the last 4 weeks. In a related news, The Securities and Exchange Commission has divulged that Ellis Gary Lee, officer (EVP & Global Ops and IT) of Medtronic Plc, had unloaded 35,495 shares at an average price of $88.64 in a transaction dated on July 13, 2016. The total value of the transaction was worth $3,146,277.
Medtronic plc (NYSE:MDT): On Mondays trading session , Opening price of the stock was $88.43 with an intraday high of $88.6899. The bears continued to sell at higher levels and eventually sold the stock down to an intraday low of $88.005. However, the stock managed to close at $88.19, a loss of 0.19% for the day. On the previous day, the stock had closed at $88.36. The total traded volume of the day was 3,277,101 shares.
Medtronic plc (Medtronic) is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group. The Cardiac and Vascular Group segment includes Cardiac Rhythm & Heart Failure, Coronary & Structural Heart and Aortic & Peripheral Vascula. Its Minimally Invasive Technologies Group segment includes Surgical Solutions and Patient Monitoring and Recovery. Its Restorative Therapies Group segment includes Spine, Neuromodulation, Surgical Technologies and Neurovascular. Its Diabetes Group segment includes Intensive Insulin Management, Non-Intensive Diabetes Therapies and Diabetes Services & Solutions. Medtronic, Inc. is a subsidiary of the Company.